Bob Lederer RBDR

Another Study Claims SM Advertising to be a Hoax | RBDR

June 7, 2017. Today on RBDR:

1) An 18-month (and running) study from Good Growth Ltd. involving its clients states that investment in social media advertising shows ROI so poor that it is best described as a hoax.

2) TiVo won two preliminary patent infringement decisions against Comcast, Arris and Technicolor.

RBDR is sponsored this week by Symmetric Sampling, a division of Decision Analyst, providing sampling services to companies that place a very high value on representative samples, scientific sampling methods, and advanced fraud-detection systems. Learn more by visiting their website.

No need to spend time “searching” for today’s RBDR video. Subscribe to receive a FREE, personal email as soon as the new RBDR is uploaded. Click here.

Bob Lederer RBDR

The Most Requested Metrics for MR CMO’s, Corporate Marketers | RBDR

January 26th, 2017. Today on RBDR:

1) Revelations about the most requested metrics and KPIs delivered to CMOs and corporate marketers.

2) TiVo loses an important round in federal court in its lawsuit against Kantar.

RBDR is sponsored this week by Burshek Research & Consulting, helping executives obtain uniquely rich and accurate market feedback so they can present, package, position, price and market brands, products and services with maximum market appeal and adoption.

In this week’s videos, watch President John Burshek’s very brief message for RBDR viewers about the upcoming webinar that points out why certain companies, particularly Amazon, have such successful customer centric programs. See it here.

Click here to sign up for Burshek Research & Consulting’s webinar on “Succeeding in Your Customer Centricity.”

No need to go on a “search” for today’s RBDR video. Subscribe for FREE and receive a personal email Monday – Thursday when the new RBDR is uploaded at about 7AM Central. Click here.

Bob Lederer RFL Communications, Inc.

Media MR News from ARF ReThink with Bill Harvey (RBDR–3/27/2014)

Sponsored by KL Communications (http://www.klcommunications.com), THE experts in Customer Co-Creation, whose proprietary CrowdWeaving™ platform is powering the next generation of online insight communities.

Check out KL Communications’ latest newsletter for
insights into implementation of novel MR tools & techniques:

http://www.klcimages.com/klcnewsletter/marchnewsletter

Today: Bob Lederer gets an insider’s media research news update at ARF’s Annual Conference from the esteemed Bill Harvey. Subjects include neuroscience’s major jump into prominence thanks to an endorsement from ARF, introduction of new CBS TV network research and the cross-platform link between TiVo and Symphony Advanced Media.

Bob Lederer RFL Communications, Inc.

TiVo study of binge and videostream viewing; Good & Bad of marketing/predictive analytics with marketing research (RBDR–1/13/2014)

Today on RBDR…

1) Tivo decided to study the new television phenomenon known as “binge viewing,” and to delve into the relatively new streaming-video-viewing trend.

2) Marketing authority and Black Ink President Jeff Winsper speaks about the threat posed by and positive potential opportunities for MR offered by marketing/predictive analytics.

Sponsored by Socratic Technologies, whose proprietary tools and methodologies tackle marketing complexities so that you can make more confident business decisions.

Research Business DAILY Report is produced by RFL Communications (rflonline.com), publisher of 4 market research newsletters that strongly complement these MR news videos:
• Research Business Report (technological and methodological changes that economically and constructively impact MR)
• Research Conference Report (summarizing conference speeches from around the world that present ideas, philosophies, methods, tactics, etc. that break new ground)
• Research Department Report (profiling the inner workings of MR departments at leading companies around the world)
• Pharma Market Research Report (the World’s Only Publication that exclusively covers the interests, challenges, opportunities, etc. of MR professionals inside pharmaceutical, health care, biotech and medical device companies)